NasdaqCM - Nasdaq Real Time Price • USD
BioRestorative Therapies, Inc. (BRTX)
As of 11:20 AM EDT. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| ALSTODT LANCE Chief Executive Officer | Purchase | Sep 15, 2023 | 189,505 |
| BROADRICK DALE Beneficial Owner of more than 10% of a Class of Security | Purchase | Feb 9, 2024 | -- |
| CATELL ROBERT B Director | Purchase | May 9, 2018 | 80,866 |
| DESMARAIS JOHN M Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) | Mar 1, 2017 | 493,398 |
| KRISTAL ROBERT EUGENE Chief Financial Officer | Purchase | Jun 15, 2022 | 7,994 |
| RADOV A JEFFREY Director | Purchase | Aug 28, 2019 | 24,500 |
| RYAN CHARLES S Director | Stock Award(Grant) | Mar 1, 2017 | 42,917 |
| SILVA FRANCISCO Officer and Director | Purchase | Apr 9, 2024 | 167,895 |
| TONNA PAUL JUDE Director | Purchase | Aug 29, 2019 | 123,850 |
| WEINREB MARK Chief Executive Officer | Purchase | Sep 6, 2019 | 117,000 |
Related Tickers
SPRC SciSparc Ltd.
1.2700
-1.55%
ALLR Allarity Therapeutics, Inc.
1.5100
-1.95%
ELYM Eliem Therapeutics, Inc.
4.1000
-1.91%
SNGX Soligenix, Inc.
0.3970
-8.80%
ONVO Organovo Holdings, Inc.
1.1300
-1.74%
PALI Palisade Bio, Inc.
4.5550
-10.16%
CLNN Clene Inc.
0.3200
-3.00%
PXMD PaxMedica, Inc.
0.7822
+2.50%
LGVN Longeveron Inc.
2.0150
+0.25%
VNDA Vanda Pharmaceuticals Inc.
5.03
+1.11%